BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 24629163)

  • 21. Melasma in men. A clinical and histologic study.
    Vázquez M; Maldonado H; Benmamán C; Sánchez JL
    Int J Dermatol; 1988; 27(1):25-7. PubMed ID: 3346120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utilizing fractional resurfacing in the treatment of therapy-resistant melasma.
    Tannous ZS; Astner S
    J Cosmet Laser Ther; 2005 Mar; 7(1):39-43. PubMed ID: 16020216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study of the incidence and nature of "very subtle epidermal melasma" in relation to intense pulsed light treatment.
    Negishi K; Kushikata N; Tezuka Y; Takeuchi K; Miyamoto E; Wakamatsu S
    Dermatol Surg; 2004 Jun; 30(6):881-6; discussion 886. PubMed ID: 15171766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PDZK1 upregulation in estrogen-related hyperpigmentation in melasma.
    Kim NH; Cheong KA; Lee TR; Lee AY
    J Invest Dermatol; 2012 Nov; 132(11):2622-31. PubMed ID: 22696060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The dermal stem cell factor and c-kit are overexpressed in melasma.
    Kang HY; Hwang JS; Lee JY; Ahn JH; Kim JY; Lee ES; Kang WH
    Br J Dermatol; 2006 Jun; 154(6):1094-9. PubMed ID: 16704639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploratory Study of Epidermis, Basement Membrane Zone, Upper Dermis Alterations and Wnt Pathway Activation in Melasma Compared to Adjacent and Retroauricular Skin.
    Espósito ACC; Brianezi G; de Souza NP; Miot LDB; Miot HA
    Ann Dermatol; 2020 Apr; 32(2):101-108. PubMed ID: 33911720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How hormones may modulate human skin pigmentation in melasma: An in vitro perspective.
    Cario M
    Exp Dermatol; 2019 Jun; 28(6):709-718. PubMed ID: 30883945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of Endothelin-1, Endothelin Receptor-A, and Endothelin Receptor-B in facial melasma compared to adjacent skin.
    da Silva CN; Miot HA; Grassi TF; Dias-Melício LA; Santos L; Espósito ACC
    Clin Cosmet Investig Dermatol; 2023; 16():2847-2853. PubMed ID: 37850109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adaptability of melanocytes post ultraviolet stimulation in patients with melasma.
    Wang YJ; Chang CC; Wu YH; Huang L; Shen JW; Lu ME; Chiang HM; Lin BS
    Lasers Surg Med; 2023 Sep; 55(7):680-689. PubMed ID: 37365922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of ex vivo melanogenic response to UVB, UVA, and visible light in facial melasma and unaffected adjacent skin.
    Alcantara GP; Esposito ACC; Olivatti TOF; Yoshida MM; Miot HA
    An Bras Dermatol; 2020; 95(6):684-690. PubMed ID: 33010989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Skin-lightening effects of a new face care product in patients with melasma.
    Scherdin U; Bürger A; Bielfeldt S; Filbry A; Weber T; Schölermann A; Wigger-Alberti W; Rippke F; Wilhelm KP
    J Cosmet Dermatol; 2008 Mar; 7(1):68-75. PubMed ID: 18254815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A clinical, dermoscopic, histopathological and immunohistochemical study of melasma and facial pigmentary demarcation lines in the skin of color.
    Khunger N; Kandhari R; Singh A; Ramesh V
    Dermatol Ther; 2020 Nov; 33(6):e14515. PubMed ID: 33169501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pilot study of an automated method to determine Melasma Area and Severity Index.
    Tay EY; Gan EY; Tan VWD; Lin Z; Liang Y; Lin F; Wee S; Thng TG
    Br J Dermatol; 2015 Jun; 172(6):1535-1540. PubMed ID: 25641313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early clinical and histological changes induced by microneedling in facial melasma: A pilot study.
    Cassiano DP; Espósito ACC; Hassun KM; Lima EVA; Bagatin E; Miot HA
    Indian J Dermatol Venereol Leprol; 2019; 85(6):638-641. PubMed ID: 31607716
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of tranexamic acid on melasma: a clinical trial with histological evaluation.
    Na JI; Choi SY; Yang SH; Choi HR; Kang HY; Park KC
    J Eur Acad Dermatol Venereol; 2013 Aug; 27(8):1035-9. PubMed ID: 22329442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased expression of nerve growth factor receptor and neural endopeptidase in the lesional skin of melasma.
    Bak H; Lee HJ; Chang SE; Choi JH; Kim MN; Kim BJ
    Dermatol Surg; 2009 Aug; 35(8):1244-50. PubMed ID: 19438666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bandlike melasma mimicking linear morphea ("en coup de sabre" type).
    Tabata H; Yamakage A; Yamazaki S
    Cutis; 1998 Apr; 61(4):225-6. PubMed ID: 9564596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pendulous melanocytes: a characteristic feature of melasma and how it may occur.
    Lee DJ; Park KC; Ortonne JP; Kang HY
    Br J Dermatol; 2012 Mar; 166(3):684-6. PubMed ID: 21936855
    [No Abstract]   [Full Text] [Related]  

  • 39. Histological classification of melasma with reflectance confocal microscopy: a pilot study in Chinese patients.
    Liu H; Lin Y; Nie X; Chen S; Chen X; Shi B; Tian H; Shi Z; Yu M; Zhang D; Yang B; Wang G; Wu M; Zhang F
    Skin Res Technol; 2011 Nov; 17(4):398-403. PubMed ID: 21332810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tape stripping and lipidomics reveal skin surface lipid abnormity in female melasma.
    Xu J; Lu H; Luo H; Hu Y; Chen Y; Xie B; Du X; Hua Y; Song X
    Pigment Cell Melanoma Res; 2021 Nov; 34(6):1105-1111. PubMed ID: 33974351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.